Sona Nanotech Inc (TSE:SONA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sona Nanotech Inc. has successfully completed a private placement, raising $1.643 million in gross proceeds, which will fund the advancement of a novel cancer therapy and general corporate purposes. The company’s innovative Targeted Hyperthermia Therapy, using heat to combat tumors, is expected to undergo a first-in-human clinical trial. Despite the related-party transactions involved, the financing adheres to regulatory exemptions, ensuring minority shareholder protection.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.